Speaker illustration

Doctor Zi-Wen Zhao

Union Hospital, Fujian Medical University,, Fuzhou (China)

Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study

Event: ESC CONGRESS 2019

Topic: Biomarkers

Session: Acute Coronary Syndromes: Biomarkers

Thumbnail

This platform is supported by

logo Novo Nordisk